Calm Seas For This Rare 11% Yielder

Calm Seas For This Rare 11% Yielder

Most very high yields are not safe. In fact, of the companies ranked by SafetyNet Pro with the 20 highest yields, 15 are rated Fs and two are rated Ds. It’s not too common to find a double-digit yield with a strong dividend safety rating. But today’s stock, which sports an impressive 11% yield, should inspire confidence […]
Hot Options Report For End Of Day – Wednesday, August 30

Hot Options Report For End Of Day – Wednesday, August 30

 
An Early Warning Sign Or Another Buy Signal?

An Early Warning Sign Or Another Buy Signal?

Despite everyone’s growing concerns with… well… you name it – the economy, the president, the missiles popping off in Pyongyang – U.S. stocks are having a pretty good year. Not as good as foreign stocks, as I explained two weeks ago. But still, the S&P 500 is up 9% year-to-date. That’s roughly the long-term average for annual returns. So, really, what’s there to […]
Korean Missiles, Killer Storm, & Kuroda Spark Biggest Buying-Panic In Tech Stocks Since Election

Korean Missiles, Killer Storm, & Kuroda Spark Biggest Buying-Panic In Tech Stocks Since Election

For today’s stock market recap, see yesterday! Video length: 00:00:05 In a comedic case of deja vu, somebody flicked the “DUMP VIX, BUY NASDAQ” switch at exactly the moment US equity markets opened… The Dow fell back into the red into the close and there was some selling pressure ahead of tomorrow’s month-end, but still, […]
Pros And The Cons Of Early Retirement

Pros And The Cons Of Early Retirement

Unless you are one of the lucky few who absolutely love their job, you probably dream of an early retirement. Not having to wake up to a blaring alarm clock each day and go through the motions of the daily grind seems like sheer bliss. However, early retirement is not that simple, and even those […]
Pentair: 40 Years Of Dividend Increases And Double-Digit Payout Growth Potential

Pentair: 40 Years Of Dividend Increases And Double-Digit Payout Growth Potential

With 40 straight years of dividend growth under its belt, Pentair (PNR) is a dividend aristocrat that is just a decade away from joining an even more elite club, the dividend kings. Over the past three decades, Pentair shareholders have enjoyed dividend growth that’s not only been remarkably consistent, but strong as well (8.9% annual payout growth). Let’s […]
September 2017 Economic Forecast: Is Personal Income To Spending Ratio A Headwind To Better Economic Growth?

September 2017 Economic Forecast: Is Personal Income To Spending Ratio A Headwind To Better Economic Growth?

Econintersect’s Economic Index continues to remain in a tight range indicating static economic growth fundamentals for the fifth month in a row. However, this tight range remains in territory associated with normal growth. Six-month employment growth forecast is now indicating little change in the rate of employment growth. Please share this article – Go to very top […]
3 Strong Buy Northern Mutual Funds For Striking Returns

3 Strong Buy Northern Mutual Funds For Striking Returns

Founded in 1889, Northern Trusts manages assets worth over $1 trillion (as of June 30, 2017) based on assets raised in the country. The company generally focuses on funds that have long-term performance. Moreover, all the Northern funds bear no sales load, making them strong investment choices for those seeking low-cost funds. Northern Trusts is one […]
Three Things I Think I Am Thinking About – Disaster Edition

Three Things I Think I Am Thinking About – Disaster Edition

Here are some things I think I am thinking about: 1. Floyd Mayweather – Maybe not such a financial disaster? Floyd Mayweather didn’t follow my financial advice. He was, predictably, MUCH better than Conor McGregor at boxing. Actually, I’d say Conor surpassed expectations. But Floyd is Floyd. He’s the best ever. And he proved it again […]
FDA Approves Futuristic New Cancer Therapy, To Cost $475,000, Sending Biotechs Surging

FDA Approves Futuristic New Cancer Therapy, To Cost $475,000, Sending Biotechs Surging

The FDA on Wednesday opened a new era in cancer treatment, when it approved a landmark, futuristic new gene therapy-based approach to treat childhood leukemia, one which has produced unprecedented results in patients with the deadly cancer. Even the FDA called the approval “historic.” “We’re entering a new frontier in medical innovation with the ability to reprogram […]